Editorial: Molecular Mechanisms of Proteinuria, Volume II
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Heerspink H, Greene T, Tighiouart H, Gansevoort R, Coresh J, Simon A
. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol. 2019; 7(2):128-139.
DOI: 10.1016/S2213-8587(18)30314-0.
View
2.
Chen A, Yin L, Lee K, He J
. Similarities and Differences between COVID-19-Associated Nephropathy and HIV-Associated Nephropathy. Kidney Dis (Basel). 2022; 8(1):1-12.
PMC: 8805054.
DOI: 10.1159/000520235.
View
3.
Guery B, Choukroun G, Noel L, Clavel P, Rotig A, Lebon S
. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol. 2003; 14(8):2099-108.
DOI: 10.1097/01.asn.0000080180.51098.02.
View
4.
Coresh J, Heerspink H, Sang Y, Matsushita K, Arnlov J, Astor B
. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 2019; 7(2):115-127.
PMC: 6379893.
DOI: 10.1016/S2213-8587(18)30313-9.
View
5.
Daehn I, Duffield J
. The glomerular filtration barrier: a structural target for novel kidney therapies. Nat Rev Drug Discov. 2021; 20(10):770-788.
PMC: 8278373.
DOI: 10.1038/s41573-021-00242-0.
View